Undiagnosed Disease Network collaborative approach in diagnosing rare disease in a patient with a mosaic CACNA1D variant
American Journal of Medical Genetics Part A · 2024
DOI: 10.1002/ajmg.a.63597 ↗Kurz gefasst
Fallbericht in der Zeitschrift American Journal of Medical Genetics Part A, 2024. Verfasst von Kimberly M Ezell und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Medical Genetics and Genomic Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA. Hauptthemen laut MEDLINE: Calcium Channels, L-Type, Mosaicism, Rare Diseases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, NIH HHS, NICHD NIH HHS.
Abstract (Originalsprache)
The Undiagnosed Disease Network (UDN) is comprised of clinical and research experts collaborating to diagnose rare disease. The UDN is funded by the National Institutes of Health and includes 12 different clinical sites ( About Us , 2022). Here we highlight the success of collaborative efforts within the UDN Clinical Site at Vanderbilt University Medical Center (VUMC) in utilizing a cohort of experts in bioinformatics, structural biology, and genetics specialists in diagnosing rare disease. Our UDN team identified a de novo mosaic CACNA1D variant c.2299T>C in a 5‐year‐old female with a history of global developmental delay, dystonia, dyskinesis, and seizures. Using a collaborative multidisciplinary approach, our VUMC UDN team diagnosed the participant with Primary Aldosteronism, Seizures, and Neurologic abnormalities (PASNA) OMIM: 615474 due to a rare mosaic CACNA1D variant (O'Neill, 2013). Interestingly, this patient was mosaic, a phenotypic trait previously unreported in PASNA cases. This report highlights the importance of a multidisciplinary approach in diagnosing rare disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Division of Medical Genetics and Genomic Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
- Department of Chemistry, Center for Structural Biology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
- Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Butler University, Indianapolis, Indiana, USA.
- Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
ORCID-Profile: Kimberly M Ezell, Yutaka Furuta
Förderung
- NINDS NIH HHS
- NIH HHS
- NICHD NIH HHS
- NHGRI NIH HHS
- National Institutes of Health
Zitieren
APA
Ezell, K. M., Tinker, R. J., Furuta, Y., Gulsevin, A., Bastarache, L., Hamid, R., Cogan, J. D., Rives, L., Neumann, S., Corner, B., Kozuria, M., Phillips, J. A., & Undiagnosed Diseases Network (2024). Undiagnosed Disease Network collaborative approach in diagnosing rare disease in a patient with a mosaic CACNA1D variant. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.63597
Vancouver
Ezell KM, Tinker RJ, Furuta Y, Gulsevin A, Bastarache L, Hamid R, et al. Undiagnosed Disease Network collaborative approach in diagnosing rare disease in a patient with a mosaic CACNA1D variant. American Journal of Medical Genetics Part A. 2024. doi:10.1002/ajmg.a.63597
BibTeX
@article{Ezell2024,
author = {Ezell, Kimberly M and Tinker, Rory J and Furuta, Yutaka and Gulsevin, Alican and Bastarache, Lisa and Hamid, Rizwan and Cogan, Joy D and Rives, Lynette and Neumann, Serena and Corner, Brian and Kozuria, Mary and Phillips, John A and Undiagnosed Diseases Network, Undiagnosed Diseases Network},
title = {Undiagnosed Disease Network collaborative approach in diagnosing rare disease in a patient with a mosaic CACNA1D variant},
journal = {American Journal of Medical Genetics Part A},
year = {2024},
doi = {10.1002/ajmg.a.63597}
}
EUVIMED